Search

everythinglearnresearchcommunity

for

Search:↓

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Cardiomyocyte-derived media can inhibit lung cancer cell growth and movement.

Blocking certain proteins on immune cells may help treat alopecia areata.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Anti-CD19 therapy may help treat SLE and NMOSD.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Soluble CD83 speeds up wound healing and reduces scarring.

Mice with human skin protein K8 had more skin problems and cancer.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Gene knockout mice developed scars similar to human hypertrophic scars, useful for studying scar progression.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Reducing CD8+ T cell growth can stabilize alopecia areata.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Inflammation helps stem cells repair tissue by directing their behavior.